Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Certara
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Certara
-
Prikvačeni tweet
#PressRelease - More than 90% of novel new drug approvals by the US Food and Drug Administration (#FDA) in 2019 were supported by Certara#software or#consulting services. To read the full press release, visit https://bit.ly/30KgilG pic.twitter.com/ouCtNLJOmr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
On Thursday, February 13th be sure to join our
#webinar with a live Q&A session to learn how you should prepare to assess price and value through emerging assessments and novel frameworks. Register here: https://bit.ly/30UVNmq#raredisease#patientaccess#drugpricingpic.twitter.com/rcNnulSb1Y
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our 2019 best of the blog book is your guide to the
#pharmaceutical industry’s latest trends in modeling and simulation (M&S), regulatory science, and real-world value assessment. Download it here: https://bit.ly/31q6Unv#RWE#regulatoryscience#PKPD#PBPK#modelingandsimulationpic.twitter.com/CBLHK5DyYo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Certara is dedicated to supporting safer and more effective cancer drugs. https://bit.ly/2vNViip
#WorldCancerDay
#IAmAndIWill
pic.twitter.com/SkZkEDePiY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Certara is dedicated to supporting safer and more effective cancer drugs. https://bit.ly/36WBPZN
#WorldCancerDay
#IAmAndIWill
pic.twitter.com/FhfsbHHaPT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Certara proslijedio/la je Tweet
Today, we celebrate all the innovative breakthroughs that have increased the quality of life for cancer patients around the world—making cancer more beatable than ever!
#WorldCancerDay
pic.twitter.com/1PF01tXop1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ICYMI - Last week we provided a webinar that gave an overview of the major additions to the#Simcyp Simulator’s ADAM and M-ADAM models. Watch it here: https://bit.ly/2RUS6tT pic.twitter.com/Q6ginTI5cW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Looking for a new opportunity? Click here to explore some of our latest hot
#jobs: https://bit.ly/2taHtor pic.twitter.com/cEtAgpGRKc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join the Certara team! We have exciting opportunities to work with hundreds of biopharmaceutical companies, leading academic institutions, and key regulatory agencies worldwide! Find a position that fits you here: https://bit.ly/2taHtor pic.twitter.com/lQewGU9hGx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Certara is hiring an Associate Scientist within our Strategic Consulting division! This position will be based in
#Raleigh#NorthCarolina- Learn more: https://bit.ly/2taHtor pic.twitter.com/6JSXtpa3kZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Blog - Demonstrating bioequivalence (BE) with Certara’s Simcyp MechDermA Model. Read here: https://bit.ly/2S48bwp#dermal#PBPK#genericdrugspic.twitter.com/avo6mWl1ws
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join our new 3-day classroom course that teaches students to go beyond NCA! Learn to model and simulate individual and population data. Session coming up 24-26 March 2020 in
#SanDiego. To learn more and register, visit https://bit.ly/38TslA0#PKPD#Trainingpic.twitter.com/aI4MnmO1oK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Certara proslijedio/la je Tweet
As competition for increasingly constrained healthcare budgets continues to rise, learn about some of the most common tools
#pharma and#medtech field teams are using to secure market access: https://bit.ly/301f7xP#marketaccess#valuecommunicationpic.twitter.com/fm9SNPzqU2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Don't miss out on our first webinar of 2020! Tomorrow we will present, "Updates to the Simcyp Simulator’s Oral Absorption ADAM and M-ADAM Models." Register now: https://bit.ly/2ZYtlzl pic.twitter.com/soWP2gsp6Z
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
[2/13 Webinar] We'll discuss how pricing has evolved from the 1990s to today for the rare disease drug market and much more! Register here: https://bit.ly/30UVNmq pic.twitter.com/Xpf0QIrrtA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Certara University is offering LIVE online classroom course focused on learning Noncompartmental analysis (NCA) using Phoenix WinNonlin. To learn more and register, visit https://bit.ly/2uvUOwQ pic.twitter.com/zctS9bWgBa
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Free! A compilation of Certara’s biggest challenges and accomplishments in model-informed drug development, health economics/outcomes research and real world evidence, and regulatory science, strategy, and services. To download the blog book, visit https://bit.ly/2RhpSsV pic.twitter.com/aptbxrqz9f
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Certara proslijedio/la je Tweet
Precision medicine - a reality or just hype? In this opinion article, the authors from
@Certara,@MonashUni,@UniofAdelaide and@OfficialUoM, provide a overview of precision medicine using model-informed precision dosing as an example
https://f1000research.com/articles/8-1709 #medicine#Healthpic.twitter.com/fKCs4Uuwll
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Certara proslijedio/la je Tweet
Global Head of Transparency & Disclosure,
@nirpy, delving in to prospective & retrospective analyses of clinical disclosure & data sharing requirements.#thoughtleadership#transparency#clinicaltrialdisclosurepic.twitter.com/B8pEDkPoG9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
[1/29 Webinar] Learn about recent additions to the ADAM/M-ADAM mechanistic models in version 19 of the Simcyp Population-based PBPK Simulator. Register here: https://bit.ly/2ZYtlzl pic.twitter.com/L1jfFTojBf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.